BSE filing, NSE: BABA. Summary written from the filing by ALFA Finder's alert engine.
Baba Arts Ltd: key numbers
- Share price
- ₹26.24
- Market cap
- ₹137.8 Cr
- Revenue (annual)
- ₹14.95 Cr
- Net profit (annual)
- ₹0.65 Cr
- P/E (TTM)
- 303.7×Sector 28.9×
- Promoter holding
- 74.68%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Baba Arts Ltd
All →Baba Arts Management Change
Baba Arts Limited's Company Secretary and Compliance Officer, Naishadh Mankad, resigned effective 6 November 2026. Shilpi Shukla was appointed to the same role from that date.
Baba Arts Promoter Reclassification
Baba Arts' board noted promoters Gordhan and Rahul Tanwani's request to reclassify as public shareholders. Company Secretary Naishadh Mankad resigned and Shilpi Shukla was appointed.
Baba Arts Promoter Buying (Off-Market): ₹3.9 Cr
Promoter entity Skybridge Interactive LLP acquired 65,00,000 equity shares of Baba Arts Ltd via an off-market transaction. The acquisition, valued at ₹3.90 Crore, increased the promoter stake from 62.28% to 74.67%.
- Value
- ₹3.90 Cr
- Promoter stake change
- +12.39%
Baba Arts Capital Structure Change
Skybridge Interactive LLP, a non-promoter acquirer, disclosed under Reg 29(2) that it acquired 65,00,000 shares of Baba Arts, raising its stake from 62.28% to 74.67%. The acquisition was off-market under a share purchase agreement dated 25 February 2026.
Baba Arts Annual General Meeting
Baba Arts Limited reported the outcome of its 27th AGM held on 3 November 2026 via video conferencing. All notice resolutions, including adoption of accounts and director appointments, were approved by majority.
Baba Arts Other Announcement
Gordhan P. Tanwani transferred 65,00,000 shares to Skybridge Interactive LLP off-market on 3 November 2026. The PIT Regulation 7(2) disclosure states no transaction price.
Other regulatory approval announcements
All →Sandur Manganese & Iron Ores Regulatory Approval
Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.
- iron ore RoM capacity
- 9.42 MTPA
Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Arihant Capital Markets Regulatory Approval
Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.
Dr. Reddy's Laboratories Regulatory Approval
Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.
Alembic Pharmaceuticals Regulatory Approval
Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.
Emmbi Industries Regulatory Approval
SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.